DIADEME’ project awarded €6.5 million in government funding via France 2030, enabling Ciloa to advance development of its bio-drug APN-sEV (Adiponectin associated with exosomes), the world’s only ...

Inhaled Antifungals Market to Reach $450 Million by 2025, Fueled by Rising Adoption in Invasive Fungal Infections The global inhaled antifungals market is projected to reach $450 million in 2025, ...

MMJ-001 Marks a Pharmaceutical First in Cannabis Medicine with FDA-Grade Formulation for a Devastating Neurological Disorder while awaiting final FDA approval for use in clinical trials. WASHINGTON, D ...

ANGLE plc celebrates 100 peer-reviewed studies validating its Parsortix® system, enhancing cancer diagnostics and personalised treatment strategies.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Responding to Dr Penny Dash’s review of patient safety across the health and care landscape, Matthew Taylor, chief executive of the NHS Confederation, said: “Patient empowerment is crucial to the ...

UCB’s continued commitment to leading research aimed at improving treatment outcomes for people living with neurological conditions.Data include the use of FINTEPLA®▼ (fenfluramine)1 in Dravet ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that its drug Pepaxti has been included in new clinical practice guidelines ...

Live-In Care is the Solution to England’s Discharge CrisisAs NHS hospitals continue to face serious pressure from delayed discharges, Noble Live-In Care is calling for live-in care to be routinely ...

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five ...

OncoZenge Appoints Tuulikki Lindmark as Head of CMC in Phase 3 Sponsor TeamOncoZenge AB (publ) ("OncoZenge" or "the Company") announces today that the sponsor team for the phase 3 project with ...

The Global Metaverse in Medical Training Market is expected to witness a growth rate of 8-9% in the next five years. Enhanced ...